What is Acadia Pharmaceuticals's interest expense?

Acadia Pharmaceuticals (ACAD) reported interest expense of $8.06M in Q1 2026.

How has Acadia Pharmaceuticals's interest expense changed year-over-year?

Acadia Pharmaceuticals's interest expense increased by 1.9% year-over-year, from $7.9M to $8.06M.

What is the long-term trend for Acadia Pharmaceuticals's interest expense?

Over 4 years (2021 to 2025), Acadia Pharmaceuticals's interest expense has grown at a 170.7% compound annual growth rate (CAGR), from $591K to $31.72M.

What does interest expense mean?

Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

Acadia Pharmaceuticals ACAD Interest Expense

Interest Expense at other companies

PTC TherapeuticsPTCT

-$49.03M-43.8%

BridgeBio PharmaBBIO

$12.94M-28.6%

TG TherapeuticsTGTX

$7.67M+13.5%

Arrowhead ResearchARWR

$23.85M+10.2%

Amneal Pharmaceuticals, Inc.AMRX

-$53.36M+6.3%

BiogenBIIB

——

Segments

By segment

See full

Reportable Segment Aggregation Before Other Operating-$8.06M-1.9%

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.7B+37.0%

Enterprise value$3.47B+36.6%

P/E9.9×-2.0×

P/S3.4×+0.7×

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's interest expense?: Acadia Pharmaceuticals (ACAD) reported interest expense of $8.06M in Q1 2026.
How has Acadia Pharmaceuticals's interest expense changed year-over-year?: Acadia Pharmaceuticals's interest expense increased by 1.9% year-over-year, from $7.9M to $8.06M.
What is the long-term trend for Acadia Pharmaceuticals's interest expense?: Over 4 years (2021 to 2025), Acadia Pharmaceuticals's interest expense has grown at a 170.7% compound annual growth rate (CAGR), from $591K to $31.72M.
What does interest expense mean?: Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.